https://www.marketscreener.com/quote/stock/HALOZYME-THERAPEUTICS-INC-50245/news/Positive-Topline-Results-Reported-from-Bristol-Myers-Squibb-s-Phase-3-CheckMate-67T-Trial-of-Subcuta-45102160/?utm_source=telegram&utm_medium=social&utm_campaign=share